glaucoma

ELIOS combined with cataract surgery delivers significant IOP reduction out to 8 years

(PRESS RELEASE) LOS ANGELES, CA, United States, 17-Feb-2022 — /EuropaWire/ — Elios Vision Inc. announced today 8-year follow up results…

2 years ago

ZEISS presents its cross-platform ophthalmic digital portfolio at the ESCRS & EURETINA exhibition

During the combined exhibition of the European Society of Cataract & Refractive Surgeons (ESCRS) and the European Society of Retina…

6 years ago

Alcon announces an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018…

6 years ago

Eye care leader Alcon to launch the CyPass® Micro-Stent at AAO annual meeting in Chicago

Alcon to host first live training program on the use of the CyPass® Micro-Stent, a minimally invasive glaucoma surgical device…

8 years ago

University of Liverpool researchers use latest technologies to identify the genes responsible for glaucoma

LIVERPOOL, 16-12-2014 — /EuropaWire/ — Researchers at the University of Liverpool are using the latest technologies to identify the genes…

9 years ago